08:54 AM EDT, 06/10/2025 (MT Newswires) -- Health care stocks were mixed pre-bell Tuesday as the Health Care Select Sector SPDR Fund (XLV) was slightly lower and the iShares Biotechnology ETF (IBB) was up 0.3% recently.

Insmed ( INSM ) shares were more than 25% higher after the company said its phase 2b study evaluating treprostinil palmitil inhalation powder in patients with pulmonary arterial hypertension, or PAH, met its primary endpoint and all secondary efficacy endpoints.